Correlation Between Akeso, and Moderna
Can any of the company-specific risk be diversified away by investing in both Akeso, and Moderna at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akeso, and Moderna into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akeso, Inc and Moderna, you can compare the effects of market volatilities on Akeso, and Moderna and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akeso, with a short position of Moderna. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akeso, and Moderna.
Diversification Opportunities for Akeso, and Moderna
Excellent diversification
The 3 months correlation between Akeso, and Moderna is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Akeso, Inc and Moderna in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Moderna and Akeso, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akeso, Inc are associated (or correlated) with Moderna. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Moderna has no effect on the direction of Akeso, i.e., Akeso, and Moderna go up and down completely randomly.
Pair Corralation between Akeso, and Moderna
Assuming the 90 days horizon Akeso, Inc is expected to generate 2.06 times more return on investment than Moderna. However, Akeso, is 2.06 times more volatile than Moderna. It trades about 0.13 of its potential returns per unit of risk. Moderna is currently generating about -0.29 per unit of risk. If you would invest 568.00 in Akeso, Inc on August 25, 2024 and sell it today you would earn a total of 312.00 from holding Akeso, Inc or generate 54.93% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 98.46% |
Values | Daily Returns |
Akeso, Inc vs. Moderna
Performance |
Timeline |
Akeso, Inc |
Moderna |
Akeso, and Moderna Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Akeso, and Moderna
The main advantage of trading using opposite Akeso, and Moderna positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akeso, position performs unexpectedly, Moderna can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Moderna will offset losses from the drop in Moderna's long position.Akeso, vs. Pintec Technology Holdings | Akeso, vs. National Beverage Corp | Akeso, vs. Celsius Holdings | Akeso, vs. Univest Pennsylvania |
Moderna vs. CureVac NV | Moderna vs. Novavax | Moderna vs. Ocean Biomedical | Moderna vs. Enveric Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Complementary Tools
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Equity Valuation Check real value of public entities based on technical and fundamental data |